Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Charles River Laboratories International Inc shares valued at $61,000 were purchased by Joseph LaPlume on Aug 22 ’25. At $152.50 per share, Joseph LaPlume acquired 400 shares.
Also, LaPlume Joseph W sold 800 shares, netting a total of over 126,080 in proceeds. Following the sale of shares at $157.60 each, the insider now holds 24,116 shares.
Before that, WALLMAN RICHARD F had added 22,500 shares to its account. In a trade valued at $3,420,000, the Former Director bought Charles River Laboratories International Inc shares for $152.00 each.
As published in a research note from William Blair on October 06, 2025, Charles River Laboratories International Inc [CRL] has been rated up from a Mkt perform to an Outperform. Analysts at Barclays upgraded the stock from ‘”an Equal weight”‘ to ‘”an Overweight”‘ outlook in a report released in early October. As of September 09, 2025, Jefferies has increased its “Hold” rating to a “Buy” for CRL. Earlier on July 09, 2025, Citigroup upgraded its rating. Their new recommendation was “a Buy” for CRL stock which previously was a “a Neutral”.
Analyzing CRL Stock Performance
On last trading session, Charles River Laboratories International Inc [NYSE: CRL] plunged -0.77% to $172.14. The stock’s lowest price that day was $171.3, but it reached a high of $174.73 in the same session. During the last five days, there has been a drop of approximately -1.84%. Over the course of the year, Charles River Laboratories International Inc shares have dropped approximately -9.03%. Shares of the company reached a 52-week high of $193.56 on 01/07/25 and a 52-week low of $91.86 on 04/11/25.
Support And Resistance Levels for Charles River Laboratories International Inc (CRL)
According to the 24-hour chart, there is a support level at 170.72, which, if violated, would cause prices to drop to 169.29. In the upper region, resistance lies at 174.15. The next price resistance is at 176.15. RSI (Relative Strength Index) is 60.78 on the 14-day chart, showing neutral technical sentiment.
Is Charles River Laboratories International Inc subject to short interest?
Stocks of Charles River Laboratories International Inc saw a sharp steep in short interest on 2025-09-15 dropping by -0.45 million shares to 2.56 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 3.02 million shares. A decline of -17.67% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.38 of the overall float, the days-to-cover ratio (short ratio) decline to 3.38.
Which companies own the most shares of Charles River Laboratories International Inc (CRL)?
In terms of Charles River Laboratories International Inc share price expectations, FactSet research, analysts set an average price target of 195 in the next 12 months, up nearly 12.41% from the previous closing price of $173.47. Analysts anticipate Charles River Laboratories International Inc stock to reach 200 by 2025, with the lowest price target being 195. In spite of this, 9 analysts ranked Charles River Laboratories International Inc stock as Buy at the end of 2025. On May 23, 2025, Redburn Atlantic assigned a price target of “a Buy” to the stock and upgraded coverage with a $182.
